Cargando…

HBV and HDV: New Treatments on the Horizon

Despite the accumulating knowledge, chronic hepatitis B (CHB) and HDV infection represent a global health problem, and there are still several critical issues, which frequently remain uncovered. In this paper, we provided an overview of the current therapeutic options and summarized the investigatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuccaro, Valentina, Asperges, Erika, Colaneri, Marta, Marvulli, Lea Nadia, Bruno, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471459/ https://www.ncbi.nlm.nih.gov/pubmed/34575165 http://dx.doi.org/10.3390/jcm10184054

Ejemplares similares

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

Hepatitis Delta Virus: HDV-HBV Interactions
por: Sureau, Camille
Publicado: (2006)

Key Factors for “Fishing” NTCP as a Functional Receptor for HBV and HDV
por: Yan, Huan, et al.
Publicado: (2023)

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
por: Costante, Federico, et al.
Publicado: (2023)

The Possible Role of Gut Microbiota and Microbial Translocation Profiling During Chemo-Free Treatment of Lymphoid Malignancies
por: Zuccaro, Valentina, et al.
Publicado: (2019)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
por: Hartl, Janine, et al.
Publicado: (2012)

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
por: Mateo, Roberto, et al.
Publicado: (2023)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
por: Battistella, Sara, et al.
Publicado: (2023)

Anti-HDV seroprevalance among patients with previous HBV infection
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
por: Sagnelli, Caterina, et al.
Publicado: (2021)

Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
por: Giersch, Katja, et al.
Publicado: (2017)

Are people previously infected with SARS-CoV-2 likely to experience COVID-19 symptoms again after vaccination? Results from an Italian COVID-19 referral center
por: Colaneri, Marta, et al.
Publicado: (2021)

Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients
por: Schmidbauer, Caroline, et al.
Publicado: (2021)

Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study
por: Asperges, Erika, et al.
Publicado: (2023)

True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach
por: Khan, Asad U, et al.
Publicado: (2011)

HDV-Like Viruses
por: Pérez-Vargas, Jimena, et al.
Publicado: (2021)

Evaluation of miR-222 Expression in HBV Infected Patients in Comparison with HDV and HBV Co-infected Patients
por: Sokhanvar, Zahra, et al.
Publicado: (2021)

Impact of Pneumococcal Urinary Antigen Testing in COVID-19 Patients: Outcomes from the San Matteo COVID-19 Registry (SMACORE)
por: Valsecchi, Pietro, et al.
Publicado: (2021)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
por: Bazinet, Michel, et al.
Publicado: (2022)

Despite Vaccination: A Real-Life Experience of Severe and Life-Threatening COVID-19 in Vaccinated and Unvaccinated Patients
por: Colaneri, Marta, et al.
Publicado: (2022)

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
por: Burm, Rani, et al.
Publicado: (2022)

Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis
por: Hoan, Nghiem Xuan, et al.
Publicado: (2021)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
por: Kirstgen, Michael, et al.
Publicado: (2021)

Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection
por: Ossami Saidy, Ramin Raul, et al.
Publicado: (2021)

IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
por: Palatini, Massimo, et al.
Publicado: (2022)

Combination of Novel Therapies for HDV
por: Elazar, Menashe, et al.
Publicado: (2022)

A Review of HDV Infection
por: Caviglia, Gian Paolo, et al.
Publicado: (2022)

Fungal Osteomyelitis: A Systematic Review of Reported Cases
por: Asperges, Erika, et al.
Publicado: (2023)

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets
por: Colagrossi, Luna, et al.
Publicado: (2018)

HDV+HBV hepatitis reactivation due to immunossuppressive therapy for hematological malignancies – an increasingly complex challenge
por: Molagic, Violeta, et al.
Publicado: (2013)

HDV Pathogenesis: Unravelling Ariadne’s Thread
por: Tseligka, Eirini D., et al.
Publicado: (2021)

Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data
por: Bassetti, Matteo, et al.
Publicado: (2022)

Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
por: Scheller, Laura, et al.
Publicado: (2021)

PCR-Based Molecular Diagnosis of Hepatitis Virus (HBV and HDV) in HCV Infected Patients and Their Biochemical Study
por: Riaz, Muhammad Nasir, et al.
Publicado: (2016)

Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study
por: Zuccaro, Valentina, et al.
Publicado: (2023)

Underestimated Prevalence of HIV, Hepatitis B Virus (HBV), and Hepatitis D Virus (HDV) Triple Infection Globally: Systematic Review and Meta-analysis
por: Chen, Sisi, et al.
Publicado: (2022)

Hepatitis D, B and C virus (HDV/HBV/HCV) coinfection as a diagnostic problem and therapeutic challenge
por: Lorenc, Beata, et al.
Publicado: (2017)

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection
por: Tsuge, Masataka, et al.
Publicado: (2019)

Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response
por: Chida, Takeshi, et al.
Publicado: (2023)

Mortality due to COVID-19 during the pandemic: A comparison of first, secondo and third SMAtteo COvid19 REgistry (SMACORE)
por: Zuccaro, Valentina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dh3231nuogmqtu59128l9l938e